Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kangfu Anti-inflammatory Suppository for Pelvic Inflammatory Diseases
NCT04035785Phase 4Unknown
- Sponsor
- China Academy of Chinese Medical Sciences
- Start
- Jul 2019
- Primary completion
- Jul 2019
01
Overview
A Phase 4 trial of Kangfu in pelvic inflammatory disease (PID), sponsored by China Academy of Chinese Medical Sciences. Status: unknown.
02
Drugs
Kangfu
03
Conditions
pelvic inflammatory disease (PID)
Beyond the preview
Go deeper on NCT04035785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04035785.